Compass therapeutics to participate in the stifel targeted oncology days

Boston, april 10, 2024 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the company will participate in the stifel targeted oncology days taking place virtually april 16 – 17, 2024.

CMPX Ratings Summary

CMPX Quant Ranking